Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesBiomerica Inc

Biomerica Inc

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
1.61 USD 0.00(0%)
Last update at 2026-11-06T21:00:00Z
VOLUME
9073
Market Cap
6.67M

Momentum Score

…

Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies, antigens, and other substances which may exist in the human body, stools, or blood in extremely small concentrations. It sells its products for treating gastrointestinal diseases and food intolerances, as well as various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also involved in the development of InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and hp+detect, a H. Pylori diagnostic test that indicates if a patient is infected with the Helicobacter pylori bacteria. The company has strategic partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs for launching the inFoods platform in Canada. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
1.58
Low
1.78
High
52 Week Price Range
1.87
Low
4.60
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Biomerica Inc develops, manufactures and sells diagnostic tests and medical devices for clinical laboratories and point-of-care settings. Long-term growth drivers include rising demand for diagnostic testing from an aging population, expansion into point-of-care and international markets, and new product introductions that could support recurring consumables revenue.
Material risks include regulatory and reimbursement uncertainty, strong competition from larger diagnostics firms and the limited scale and stock liquidity common to small-cap medical device companies.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
1.61
Dividend Yield
-
Revenue TTM
4.33M
Revenue Per Share
1.61
Gross Profit TTM
0.19M
Debt / Equity
0.11
ROE
-94.32%
Net Debt
-1.94M
ROCE
-122.16%
Diluted EPS TTM
-1.61

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-05-31 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Type yearly yearly yearly yearly yearly
Date 2025-05-31 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Income before tax -4.97M -5.94M -7.09M -4.51M -6.46M
Net income -4.97M -5.98M -7.14M -4.53M -6.47M
Selling general administrative 4.61M 5.49M 6.08M 5.70M 4.61M
Gross profit 0.50M 0.61M 0.45M 2.98M 0.50M
Reconciled depreciation 0.40M 0.37M 0.35M 0.59M 0.38M
Ebit -5.14M -6.37M -7.22M -4.53M -6.52M
Ebitda -4.74M -5.99M -6.87M -3.91M -6.08M
Depreciation and amortization 0.40M 0.37M 0.35M 0.62M 0.44M
Non operating income net other - - - - 0.07M
Operating income -5.14M -6.37M -7.22M -4.53M -6.52M
Other operating expenses 10.45M 11.78M 12.56M 23.41M 13.72M
Interest expense - - - 0.03M 0.00M
Tax provision 0.00M 0.04M 0.05M 0.02M 0.01M
Interest income 0.17M 0.43M 0.13M 0.03M 0.07M
Net interest income 0.17M 0.43M 0.13M 0.03M 0.07M
Income tax expense 0.00M 0.04M 0.05M 0.02M 0.01M
Total revenue 5.31M 5.42M 5.34M 18.87M 7.20M
Total operating expenses 5.63M 6.98M 7.67M 7.51M 7.02M
Cost of revenue 4.81M 4.80M 4.89M 15.89M 6.70M
Total other income expense net 0.17M 0.43M 0.00M 0.03M 0.07M
Net income from continuing ops -4.97M -5.98M -7.14M -4.53M -6.47M
Net income applicable to common shares - - -7.14M -4.53M -6.47M
Breakdown 2025-05-31 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Type yearly yearly yearly yearly yearly
Date 2025-05-31 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Total assets 5.95M 9.25M 14.45M 11.37M 11.82M
Intangible assets 0.23M 0.21M 0.17M 0.17M 0.29M
Other current assets 0.26M 0.24M 0.30M 0.00M 0.00M
Total liab 1.84M 2.66M 2.73M 3.05M 2.59M
Total stockholder equity 4.11M 6.59M 11.72M 8.32M 9.23M
Other current liab 1.03M 1.50M 1.24M 0.88M 0.54M
Common stock 0.20M 1.35M 1.35M 1.03M 0.98M
Capital stock 0.20M 1.35M 1.35M 1.03M 0.98M
Retained earnings -53.17M -48.20M -42.22M -35.08M -28.39M
Other assets - - 0.08M 0.00M 0.26M
Cash 2.40M 4.17M 9.72M 5.92M 4.20M
Total current liabilities 1.74M 2.20M 1.95M 2.01M 1.30M
Current deferred revenue 0.06M 0.09M 0.06M 0.05M -
Net debt -1.94M -3.38M -8.64M -4.54M -2.58M
Short term debt 0.36M 0.33M 0.30M 0.34M 0.33M
Short long term debt total 0.46M 0.79M 1.08M 1.38M 1.62M
Other stockholder equity 57.17M 53.54M 52.70M 42.45M 36.69M
Property plant equipment - - 1.25M 1.52M 1.86M
Total current assets 4.88M 7.73M 12.80M 9.43M 9.23M
Long term investments 0.17M 0.17M 0.17M 0.17M 0.17M
Net tangible assets - - 11.56M 8.16M 8.93M
Net receivables 0.73M 0.95M 0.72M 0.77M 1.46M
Inventory 1.49M 2.38M 2.06M 2.42M 3.21M
Accounts payable 0.29M 0.29M 0.34M 0.74M 0.43M
Accumulated other comprehensive income -0.10M -0.10M -0.11M -0.07M -0.05M
Common stock total equity - - - - 0.98M
Retained earnings total equity - - - - -28.39M
Non currrent assets other 0.11M 0.20M 0.08M 0.10M 0.26M
Non current assets total 1.07M 1.52M 1.66M 1.95M 2.59M
Capital lease obligations 0.46M 0.79M 1.08M 1.38M 1.62M
Breakdown 2025-05-31 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Type yearly yearly yearly yearly yearly
Date 2025-05-31 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Investments -0.04M -0.12M -0.08M -0.17M -0.30M
Change to liabilities - - -0.08M 0.39M -0.40M
Total cashflows from investing activities -0.04M -0.12M -0.08M -0.17M -0.30M
Total cash from financing activities 2.11M -0.08M 9.39M 2.39M 1.11M
Change to operating activities - - -0.20M 0.28M 0.91M
Net income -4.97M -5.98M -7.14M -4.53M -6.47M
Change in cash -1.77M -5.55M 3.80M 1.72M -4.44M
Begin period cash flow 4.17M 9.72M 5.92M 4.20M 8.64M
End period cash flow 2.40M 4.17M 9.72M 5.92M 4.20M
Total cash from operating activities -3.84M -5.36M -5.47M -0.48M -5.25M
Issuance of capital stock 2.14M 0.00M 10.01M 2.40M 1.01M
Depreciation 0.40M 0.37M 0.35M 0.59M 0.38M
Other cashflows from investing activities - -0.06M - - -0.16M
Change to inventory 0.88M -0.12M 0.53M 1.56M -1.91M
Change to account receivables 0.21M -0.21M -0.29M 1.37M -0.46M
Sale purchase of stock - 0.00M -0.70M -0.08M -0.17M
Other cashflows from financing activities -0.03M -0.08M 0.08M 0.08M 0.27M
Change to netincome - - 1.35M -0.14M 2.69M
Capital expenditures 0.04M 0.12M 0.08M 0.17M 0.30M
Change receivables - - - - -0.46M
Cash flows other operating - - - - 1.28M
Exchange rate changes - - - - -0.01M
Cash and cash equivalents changes - - - - -4.44M
Change in working capital 0.27M -0.62M -0.04M 2.91M -1.85M
Stock based compensation 0.46M 0.84M 1.19M 1.26M 1.35M
Other non cash items 0.00M 0.03M 0.17M -0.72M 2.32M
Free cash flow -3.88M -5.48M -5.55M -0.65M -5.55M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
BMRA
Biomerica Inc		 -
-%		 1.61 - - 1.54 2.01 1.28 -5.42
ABT
Abbott Laboratories		 -0.03
0.03%		 109.93 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC		 -3.04
2.90%		 101.80 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation		 -9.21
2.75%		 325.87 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG		 -2.15
4.12%		 49.85 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

Biomerica Inc

Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies, antigens, and other substances which may exist in the human body, stools, or blood in extremely small concentrations. It sells its products for treating gastrointestinal diseases and food intolerances, as well as various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also involved in the development of InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and hp+detect, a H. Pylori diagnostic test that indicates if a patient is infected with the Helicobacter pylori bacteria. The company has strategic partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs for launching the inFoods platform in Canada. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.

17571 Von Karman Avenue, Irvine, CA, United States, 92614

949 645 2111

https://www.biomerica.com

53

Name Title Year Born
Mr. Zackary S. Irani Chairman & CEO 1966
Mr. Allen C. Barbieri Exec. Vice-Chairman & Corp. Sec. 1958
Mr. Steven Sloan CFO & Treasurer 1970
Ms. Lucy Liu Ph.D. Director of Manufacturing & Technical Operations NA
Hans Boehringer Sr. VP of POC R&D NA
Mr. Robert W. Carlson Chief Commercial Officer NA
Mr. Zackary S. Irani Chief Executive Officer 1966
Mr. Allen C. Barbieri Executive Vice-Chairman of the Board & Corporate Secretary 1958
Mr. Gary Lu CPA Principal Accounting Officer & CFO 1981
Mr. Zackary S. Irani CEO & Director 1966

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…